Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marchese

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Medical Virology|October 26, 2006
The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detectionOlivia Hammond, Yue Wang, Tina Green, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases|January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adultsDaniel M Musher, Susan B Manof, Charlie Liss, et al.
Clinical and Vaccine Immunology : CVI|August 9, 2006
Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assayRocio D Marchese, Neil T Jain, Joseph Antonello, et al.
Vaccine|March 22, 2018
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of ageSusan J Ermlich, Charles P Andrews, Steven Folkerth, et al.
The Journal of Infectious Diseases|January 22, 2010
Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = yearsSusan B Manoff, Charles Liss, Michael J Caulfield, et al.
Clinical Chemistry|May 17, 2015
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancerDavid S Guttery, Karen Page, Allison Hills, et al.
Plos One|November 9, 2013
Influence of plasma processing on recovery and analysis of circulating nucleic acidsKaren Page, David S Guttery, Nathalie Zahra, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 28, 2015
The immunohistochemical peptidergic expression of leptin is associated with recurrence of malignancy in laryngeal squamous cell carcinomaS Gallina, F Sireci, F Lorusso, et al.
Human Vaccines & Immunotherapeutics|March 23, 2016
Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomesKaren L Ciprero, Rocio D Marchese, Patrick Richard, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Medical Virology|October 26, 2006
The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detectionOlivia Hammond, Yue Wang, Tina Green, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases|January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adultsDaniel M Musher, Susan B Manof, Charlie Liss, et al.
Clinical and Vaccine Immunology : CVI|August 9, 2006
Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assayRocio D Marchese, Neil T Jain, Joseph Antonello, et al.
Vaccine|March 22, 2018
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of ageSusan J Ermlich, Charles P Andrews, Steven Folkerth, et al.
The Journal of Infectious Diseases|January 22, 2010
Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = yearsSusan B Manoff, Charles Liss, Michael J Caulfield, et al.
Clinical Chemistry|May 17, 2015
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancerDavid S Guttery, Karen Page, Allison Hills, et al.
Plos One|November 9, 2013
Influence of plasma processing on recovery and analysis of circulating nucleic acidsKaren Page, David S Guttery, Nathalie Zahra, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 28, 2015
The immunohistochemical peptidergic expression of leptin is associated with recurrence of malignancy in laryngeal squamous cell carcinomaS Gallina, F Sireci, F Lorusso, et al.
Human Vaccines & Immunotherapeutics|March 23, 2016
Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomesKaren L Ciprero, Rocio D Marchese, Patrick Richard, et al.
Pageof 6